Eli Lilly will co-develop autoimmune disease therapy under $150 million deal with Nektar By: MarketWatch July 24, 2017 at 11:33 AM EDT The therapy could treat an underlying disease but is very early in development. Read More >> Related Stocks: Eli Lilly Nektar Therapeutics